Clinical adoption IntraOp focuses on compact, mobile linear accelerators for intraoperative radiotherapy, highlighting a pathway to hospital-based procurement and capital equipment sales to oncology centers seeking point-of-care radiation options.

Clinical trials Active and upcoming FLASH radiotherapy trials and Mobetron UHDR system progress suggest opportunities to engage researchers, contract manufacturers, and clinical sites for workstreams, training, and potential device upgrade cycles.

Global presence Participation in ESTRO and AAPM conferences, plus hospital collaborations (e.g., University Hospital Southampton), indicates a network-ready approach for multi-region sales, partnerships, and international expansion of adoption.

Mid-market focus Revenue tier and employee size position IntraOp in a mid-market segment with potential upsell to larger cancer care networks, radiology departments, and academic centers seeking scalable, cost-effective radiotherapy solutions.

Affiliates and impact Existing hospital acquisitions and collaborations around Mobetron imply upside through service contracts, maintenance, training programs, and integration with hospital inventories, creating repeatable revenue streams.